Clinical Trial

Effect of Prebiotics in Saudi Adults With Type 2 Diabetes

Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study will explore how a natural food ingredient called oligofructose affects blood glucose levels, lipid profiles, inflammation biomarkers, and gut bacteria in Saudi adults with type 2 diabetes. Oligofructose is a type of dietary fiber found in foods such as onions, garlic, and bananas. It is known to help the growth of "good" bacteria in the intestine, which may improve digestion and metabolism. A total of 100 adults (50 with type 2 diabetes and 50 without diabetes) will take part in this research. Participants will be randomly assigned to receive either oligofructose or a placebo twice daily for 12 weeks. Blood tests will be done at the beginning and at weeks 4, 8, and 12 to check changes in blood glucose, lipid profiles, and inflammation. The goal of this study is to find out whether adding oligofructose to the diet can help people with diabetes improve their blood glucose control, reduce inflammation, and support a healthier balance of gut bacteria.
Trial Details
NCT Number NCT07464691
Lead Sponsor Princess Nourah Bint Abdulrahman University
Conditions Type 2 Diabetes, Metabolic Health, Inflammation, Gut Microbiome, Obesity
Enrollment 100 participants
Start Date 2026-09-13
Primary Completion 2027-09-30 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-11